Pre-clinical evaluation of novel specific PRC2 inhibitors as potential experimental therapies in biliary tract cancer
Stangassinger, L; Beyreis, M; Helm, K; Ritter, M; Neureiter, D; Kiesslich, T; Mayr, C;
Paracelsus Science Get Together 2016; 29.06.2016; Salzburg. 2016.